Le marché des dispositifs d'administration par voie nasale devrait atteindre 95 676,62 millions de dollars américains d'ici 2027, contre 58 502,18 millions de dollars américains en 2019. Le marché devrait croître avec un TCAC de 6,4 % de 2020 à 2027.
L'administration nasale de médicaments est l'une des voies d'administration de médicaments préférées des patients et des prestataires de soins de santé. Cela peut principalement être attribué à la nature non invasive de cette voie d'administration et à une plus grande capacité d'absorption du médicament par voie nasale. De plus, la voie nasale offre un environnement moins hostile aux médicaments par rapport à la voie gastro-intestinale, permettant ainsi une meilleure absorption du médicament. La facilité d'administration de ces médicaments joue un rôle crucial dans l'amélioration de l'observance des traitements médicamenteux chez les patients, ce qui à son tour détermine les résultats pour les patients. Compte tenu de ces facteurs, la préférence pour l'administration de médicaments par voie nasale augmente chez les patients ainsi que chez les prestataires de soins de santé. Étant très vasculaire, la cavité nasale améliore l'absorption du médicament, ce qui entraîne une action rapide. L'Organisation mondiale de la santé (OMS) a des lignes directrices spécifiques pour les fabricants, qui décrivent toutes les exigences nécessaires pour l'adoption de nouveaux dispositifs d'administration nasale avec un système d'administration à usage unique. Ainsi, l'administration nasale de médicaments, contrairement à d'autres voies d'administration de médicaments, ne nécessite pas de méthodes stériles rigoureuses pour administrer des médicaments dans le corps. Ainsi, la forte préférence pour l'administration nasale de médicaments parmi les patients et les prestataires de soins de santé, en raison de la prise de conscience croissante de ses avantages, stimule la croissance du marché.
Marchés régionaux lucratifs pour les dispositifs d'administration nasale
< h3>Aperçu du marché
Prévalence croissante des maladies respiratoires et du SNC
Les premières études de preuve de concept utilisant de nouveaux dispositifs d'administration nasale de médicaments ont montré des résultats prometteurs dans le traitement des maladies respiratoires, neurologiques troubles, et autres. Les dispositifs d'administration de médicaments jouent un rôle essentiel en assurant l'administration de tout le médicament au site cible dans la cavité nasale. Au cours des dernières décennies, plusieurs approches innovantes d'administration de médicaments ont été introduites qui pourraient surmonter les défis liés à la traversée de la barrière hémato-encéphalique (BHE). Plusieurs études scientifiques soutiennent la spéculation selon laquelle l'administration de médicaments par voie nasale peut permettre à des concentrations plus élevées de médicaments de traverser la BHE. L'incidence croissante des troubles neurologiques augmenterait la demande de dispositifs d'administration nasale. Selon l'American Society of Clinical Oncology (ASCO), en 2020, environ 3 540 tumeurs cérébrales et autres tumeurs du SNC ont été diagnostiquées chez des enfants appartenant à la tranche d'âge de 0 à 14 ans, aux États-Unis. Le rapport indique également que le cerveau et d'autres tumeurs du SNC sont les deuxièmes cancers les plus courants chez les enfants, représentant environ 26 % des cas de cancer chez les enfants de moins de 15 ans.
Les affections respiratoires telles que les affections respiratoires aiguës les infections des voies respiratoires inférieures, la tuberculose, la maladie pulmonaire obstructive chronique (spectre de la maladie MPOC qui comprend la bronchite et l'emphysème), l'asthme et le cancer du poumon sont parmi les causes les plus courantes de maladies graves et de décès dans le monde. L'urbanisation et la pollution croissantes, les modes de vie et les habitudes malsains et la forte prévalence du tabagisme sont parmi les facteurs qui entraînent l'augmentation des cas de maladies respiratoires et cardiovasculaires. Les voies respiratoires pourraient provoquer une insuffisance respiratoire aiguë, dont le traitement nécessite l'administration nasale de médicaments pour un soutien continu. Selon le Global Asthma Report 2018, publié par Global Asthma Network, environ 330 millions de personnes dans le monde sont asthmatiques. De plus, selon les estimations de Global Burden of Disease, un projet de recherche spécial de l'Institute for Health Metrics and Evaluation, en 2016, environ 420 000 personnes sont décédées des suites de l'asthme. Selon une étude publiée dans la National Library of Medicine des National Institutes of Health des États-Unis en 2018, la prévalence de l'asthme est constamment élevée en Corée, en particulier chez les femmes et les personnes âgées. De plus, selon le rapport de l'étude Global Burden of Disease Study, la prévalence des cas de BPCO était de 251 millions en 2016. et les pays à revenu intermédiaire (PRFI), et la maladie est susceptible de devenir l'une des principales causes de décès dans le monde au cours des 15 prochaines années. Ainsi, la prévalence croissante des maladies respiratoires, des troubles neurologiques et d'autres maladies chroniques stimule la demande pour les dispositifs d'administration nasale pour une administration efficace des médicaments sur les sites cibles.
Drug Type Insights
En fonction du type de médicament, le marché des dispositifs d'administration nasale est segmenté en anesthésiques, antibiotiques, analgésiques , suppléments de calcium, vasoconstricteurs, antihistaminiques et autres. En 2019, le segment des antihistaminiques représentait la plus grande part du marché. La croissance de ce segment est attribuée à l'augmentation de la rhinite allergique.
Marché mondial des dispositifs d'administration par voie nasale, par type de médicament - 2019 et 2027
Informations sur les technologies d'administration
Basées sur les technologies de livraison, le marché mondial des dispositifs de livraison nasale est segmenté en spray, nébuliseurs, inhalateurs et autres. En 2019, le segment des inhalateurs détenait une part importante du marché et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Informations sur l'utilisateur final
Basé sur l'utilisateur final , le marché mondial des dispositifs de délivrance nasale est segmenté en établissements de soins à domicile, hôpitaux et cliniques. En 2019, le segment des établissements de soins à domicile détenait une part importante du marché et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Perspectives stratégiques
Lancements de produits et Les approbations sont les stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits afin de répondre à la demande croissante des consommateurs. Les acteurs du marché des dispositifs d'administration nasale adoptent la stratégie de collaborations pour élargir la clientèle dans le monde entier, ce qui leur permet également de conserver leur marque à l'échelle mondiale.
Marché des dispositifs d'administration nasale - par type de médicament
- Antibiotiques
- Médicaments contre la douleur
- Suppléments de calcium
- Vasoconstricteurs
- Antihistaminiques
- Autres
< li>Anesthésiques
Marché des dispositifs d'administration nasale Par technologies d'administration
- Spray
- Nébuliseurs
- Inhalateurs
- Autres
Marché des dispositifs d'administration nasale Par utilisateur final
- Paramètres de soins à domicile
- Hôpitaux
- Cliniques
Marché des dispositifs d'administration nasale - par géographie
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'Asie-Pacifique
< /ul> - Moyen-Orient et amp ; Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du Moyen-Orient & ; Afrique
- Amérique du Sud et centrale
- Brésil
- Argentine
- Reste de l'Amérique du Sud
Profils d'entreprise
- GlaxoSmithKline plc.
- AstraZeneca
- Pfizer Inc
- BD
- Sanofi
- Merck & ; Co., Inc.
- Cadila Pharmaceuticals Ltd.
- Novartis AG
- Dr. Laboratoires Reddy
- Neurelis, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Nasal drug delivery is one of the efficient route of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.
The factors that are driving growth of the market are growing prevalence of respiratory and cns diseases and increasing preference and awareness of intranasal drug delivery among patients.Moreover, strategic activities by the manufacturersare offering lucrative opportunities for the growth of the market.
The nasal delivery devices market majorly consists of the players such as GlaxoSmithKline plc.,AstraZeneca, Pfizer Inc., BD, Sanofi, Merck & Co., Inc., Cadila Pharmaceuticals Ltd., Novartis AG, Dr. Reddy's Laboratories, and Neurelis. amongst others.
The List of Companies - Nasal delivery devices Market
- GlaxoSmithKline plc.
- AstraZeneca
- Pfizer Inc.
- BD
- Sanofi
- Merck & Co., Inc.
- Cadila Pharmaceuticals Ltd.
- Novartis AG
- Dr. Reddy's Laboratories
- Neurelis, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Oct 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Oct 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)